BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11368373)

  • 1. AML1/CBFbeta transcription complex: its role in normal hematopoiesis and leukemia.
    Downing JR
    Leukemia; 2001 Apr; 15(4):664-5. PubMed ID: 11368373
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukemogenesis by CBF oncoproteins.
    Friedman AD
    Leukemia; 1999 Dec; 13(12):1932-42. PubMed ID: 10602413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
    Miller JD; Stacy T; Liu PP; Speck NA
    Blood; 2001 Apr; 97(8):2248-56. PubMed ID: 11290585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the AML1 transcription factor in leukemogenesis.
    Lorsbach RB; Downing JR
    Int J Hematol; 2001 Oct; 74(3):258-65. PubMed ID: 11721960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of the AML1 transcription factor in human leukemia.
    Downing JR; Higuchi M; Lenny N; Yeoh AE
    Semin Cell Dev Biol; 2000 Oct; 11(5):347-60. PubMed ID: 11105899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.
    Kalev-Zylinska ML; Horsfield JA; Flores MV; Postlethwait JH; Vitas MR; Baas AM; Crosier PS; Crosier KE
    Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Core binding factor genes and human leukemia.
    Hart SM; Foroni L
    Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous cdk4 overcomes reduced cdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF - a model for overcoming inhibition of proliferation by CBF oncoproteins.
    Lou J; Cao W; Bernardin F; Ayyanathan K; RauscherIII FJ; Friedman AD
    Oncogene; 2000 May; 19(22):2695-703. PubMed ID: 10851069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core binding factor and its role in normal hematopoietic development.
    Speck NA
    Curr Opin Hematol; 2001 Jul; 8(4):192-6. PubMed ID: 11561154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The core-binding factor leukemias: lessons learned from murine models.
    Downing JR
    Curr Opin Genet Dev; 2003 Feb; 13(1):48-54. PubMed ID: 12573435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the t(8;21) translocation in acute myeloid leukaemia.
    Ohki M
    Semin Cancer Biol; 1993 Dec; 4(6):369-75. PubMed ID: 8142622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.
    Lam K; Zhang DE
    Front Biosci (Landmark Ed); 2012 Jan; 17(3):1120-39. PubMed ID: 22201794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.
    Elagib KE; Racke FK; Mogass M; Khetawat R; Delehanty LL; Goldfarb AN
    Blood; 2003 Jun; 101(11):4333-41. PubMed ID: 12576332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.
    Licht JD
    Oncogene; 2001 Sep; 20(40):5660-79. PubMed ID: 11607817
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of CBFbeta in AML1-ETO's activity.
    Park S; Speck NA; Bushweller JH
    Blood; 2009 Sep; 114(13):2849-50. PubMed ID: 19779050
    [No Abstract]   [Full Text] [Related]  

  • 17. Runx1/AML1 in leukemia: disrupted association with diverse protein partners.
    Perry C; Eldor A; Soreq H
    Leuk Res; 2002 Mar; 26(3):221-8. PubMed ID: 11792409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of AML1/Runx1 in the pathogenesis of hematological malignancies.
    Kurokawa M; Hirai H
    Cancer Sci; 2003 Oct; 94(10):841-6. PubMed ID: 14556655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX1/AML1: a central player in hematopoiesis.
    Okuda T; Nishimura M; Nakao M; Fujita Y
    Int J Hematol; 2001 Oct; 74(3):252-7. PubMed ID: 11721959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Loss-of-function of AML1/PEBP2 alpha B and leukemogenesis].
    Osato M; Ito Y; Asou N
    Tanpakushitsu Kakusan Koso; 2000 Jan; 45(1):40-7. PubMed ID: 10643334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.